HOME PAGE ›› Future ISH Meetings ›› ISH-TSH School of Hematology

ISH-TSH School of Hematology

Applications are closed as of 1st November 2017

Dear Colleague,

I am inviting you to the "School of Hematology on Benign Hematological Disorders" organized jointly by the International Society of Hematology (ISH) 

and Turkish Society of Hematology (TSH) in Antalya, Turkey on 22-24 December 2017.

The School is intended to address the educational needs of young hematologists and hematology fellows, 

both in adult and pediatric hematology

Attached please find the Scientific Program.

As the ISH - European and African Division (EAD),  we are aiming to attract participants from countries in the region, 

in particular Eastern and Central Europe, Africa and Middle East

The School has a capacity of 50 participants and all will be sponsored by the Turkish Society of Hematology (TSH)  and pharmaceutical industry. 

As the faculty and participants will be staying at the same hotel where the School will be held, 

it will allow the participants to discuss matters and share ideas of interest, not limited to the course hours. 

We will appreciate if you can come to this important ISH-EAD educational event. 

Organizing Secretariat (dilara.doger@serenas.com.tr). 

I hope this will be a productive meeting opening new ways for international collaboration 

between participants from different countries, as well as addressing their educational needs and questions.

We are looking forward to hearing from you soon.

Best regards,

Sabri KEMAHLI, M.D.   
Secretary-General, ISH-EAD
Course Coordinator
Muzaffer DEMİR, M.D.
President, Turkish Society of Hematology
Course Coordinator
Emin KANSU, M.D.
Chairman of Council, ISH

Benign Hematological Disorders
Antalya – Turkey

Dates   : Friday – Saturday – Sunday
        22 – 23 and 24 December 2017

Faculty :

  1. Miguel Abboud (Lebanon)*
  2. Sema Anak (Turkey)
  3. Cem Ar (Turkey)
  4. Yeşim Aydınok (Turkey)
  5. Yahya Büyükaşık (Turkey
  6. Reyhan Diz-Küçükkaya (Turkey)
  7. Amal El-Beshlawy (Egypt)*
  8. Fatma Gümrük (Turkey)
  9. Chaim Hershko (Israel) *
  10. Emin Kansu (Turkey)
  11. Kaan Kavaklı (Turkey)
  12. Gül Nihal Özdemir (Turkey)
  13. Duygu Uçkan (Turkey)
  14. Şule Ünal (Turkey)
  15. Elif Uğur Ümit (Turkey)
  16. Elif  Ünal İnce (Turkey
  17. Ayşegül Üner (Turkey)
  18. Ayşegül Ünüvar (Turkey)

 (*) Invited Speakers :
Miguel Abboud (Beirut, Lebanon)
Amal El-Beshlawy (Cairo, Egypt)
Chaim Hershko (Jerusalem, Israel)

Provisional Program

1st Day  Friday 22 December 2017
08:30 – 08:45 Opening Remarks

Sabri Kemahlı    
Secretary – General, ISH-EAD
Coordinator, ISH-TSH School of Hematology

Muzaffer Demir 
President of Turkish Society of Hematology (TSH)
Coordinator, ISH-TSH School of Hematology

  Session – I  : Hemoglobinopathies
08:45 – 09:10 Current Perspectives  on Hematopoiesis and Hematopoietic Stem Cells
Emin Kansu (Turkey)
09:15 – 09:40 New insights on Iron Metabolism and Iron Deficiency Anemia
Chaim Hershko (Israel)
09:45 – 10:10 Iron Overload in Thalassemias : Pathophysiology and Treatment
Fatma Gümrük (Turkey)
10:15 – 10:40 The screening programs and pre-natal diagnosis of Hemoglobinopathies : Where are we in the region ?
Yeşim Aydınok (Turkey)
10:45 – 11:05 Coffee Break
11:05 – 11:30 Thalassemia traits difficult to diagnose and the significance in marital screenings
Şule Ünal (Turkey)
11:35 – 11:50 New therapeutic approaches in Thalassemias
Amal El-Beshlawy (Egypt)
11:55 – 12:25 New science underlying potential treatment approaches for Sickle Cell Anemia
Miguel Abboud,M.D. (Lebanon)
12:30 – 13:30 Lunch
  Session – II  :  Hemostasis- Thrombosis and Storage Diseases
13:30 – 14:00 Microangiopathic Hemolytic Anemias (MAHAs) : Differential diagnosis and management                           
Elif Uğur Ümit (Turkey)
14:05 – 14:35 Emerging therapeutic options and strategies in hemophilia: Novel factor concentrates
Kaan Kavaklı (Turkey)
14:40 – 15:10  Risk factors and clinical management of inhibitor development in Hemophilia
Ayşegül Ünüvar (Turkey)
15:15 – 15:45 Hematologic Manifestations and Complications of Gaucher Disease  
Gül Nihal Özdemir (Turkey)
15:50 – 16:20 Coffee Break
16:20 – 16:50 Disseminated Intravascular Coagulation (DIC)        
Cem Ar (Turkey)
16:55 – 17:25 When and whom to screen for Hereditary Thrombophilia ? 
Reyhan Diz – Küçükkaya (Turkey)
17:30 – 18:00 Meet the Expert Session : 
Diagnostic challenges in patients with undiagnosed bleeding problems 
Reyhan Diz – Küçükkaya (Turkey) / Muzaffer Demir (Turkey)
18:00 – 18:30 General Discussion
2nd Day ,  Saturday  23 December 2017
  Session – III : Anemia and Bone Marrow Failure
09:00 – 09:25 Acquired Aplastic Anemia
Yahya Büyükaşık (Turkey)
09:30 – 09:55 Congenital Dyserythropoietic Anemias  (CDA) : Diagnosis and treatment
Elif Ünal İnce (Turkey)
10:00 – 10:45 Case Discussions
  Ayşegül Üner (Turkey)
Difficult clinical cases to be presented with hematopathologic discussions
10: 45 – 11:05 Coffee Break
11:05 – 11:30 Clinical and laboratory findings suggestive of hereditary bone marrow failures
Şule Ünal (Turkey)
11:35 – 12:00 Stem Cell Transplantation in Fanconi’s Anemia       
Duygu Uçkan (Turkey)
12:00 – 13.00 Lunch
13.00 – 13:45 Meet the Expert Session :
  Long-term follow-up of pediatric stem cell transplant  patients
Sema Anak (Turkey)
13:45 – 14:00 General Discussion
14:00 – 14.15 Evaluation of the Scientific Program
14:00 – 14.15 Certificates to the Attendees
14.15 – 14.30 Closing Remarks by
Muzaffer Demir  (TSH) and Emin Kansu (ISH)
  3rd Day  Sunday 24 December 2017
  Departures from the hotel

This website is only for professional-level audience and health professionals
LookUs & Online Makale